EMPATIN-H Tablets

EMPATIN-H Tablets
Generic Name:
Empagliflozin 25 mg + Linagliptin 5 mg
Therapeutic Group:
Antidiabetic Combination
Drug Category:
SGLT2 Inhibitor + DPP-4 Inhibitor
Content / Composition:
Each film-coated tablet contains:
Empagliflozin …………………………… 25 mg
Linagliptin ……………………………… 5 mg
Excipients ……………………………… q.s.
Indications:
EMPATIN-H is indicated for:
Type 2 Diabetes Mellitus
Improvement of glycemic control in adults inadequately controlled on monotherapy
Reduction of cardiovascular risk in patients with Type 2 Diabetes
Renal protection in diabetic patients (as part of comprehensive care)
Dosage:
One tablet once daily
Can be taken with or without food
Dose adjustment based on renal function and clinical response
As directed by the physician
Contraindications:
Hypersensitivity to empagliflozin or linagliptin
Type 1 Diabetes Mellitus
Diabetic ketoacidosis
Severe renal impairment (eGFR <30 mL/min)
Pregnancy and lactation
Administration:
Administer orally with water
Take at the same time each day
Maintain adequate hydration
Drug Interactions:
Increased risk of hypoglycemia with insulin or sulfonylureas
Diuretics may increase risk of dehydration
Rifampicin may reduce linagliptin effectiveness
Monitor when used with antihypertensive drugs
Compatibility:
Suitable for combination with metformin, insulin, or other antidiabetic agents
Compatible with comprehensive diabetes management protocols
Stability / Storage:
Store below 25°C
Protect from light, heat, and moisture
Keep out of reach of children
Precautions:
Risk of dehydration and hypotension (due to SGLT2 inhibitor)
Monitor renal function regularly
Risk of genital and urinary tract infections
Monitor blood glucose levels regularly
Educate patients about signs of ketoacidosis (rare but serious)
Use cautiously in elderly patients
Side Effects:
Common:
Increased urination
Genital infections
Urinary tract infections
Headache
Uncommon:
Hypoglycemia (especially with combination therapy)
Dizziness
Dehydration
Serious (Rare):
Diabetic ketoacidosis
Severe infections
Allergic reactions
Important Note:
EMPATIN-H is a modern fixed-dose combination for Type 2 Diabetes offering glycemic control with cardiovascular and renal benefits. It should be used under medical supervision. This information is intended for healthcare professionals and educational purposes only.